Cas:18518-71-3 chroman-3-ylamine hydrochloride manufacturer & supplier

We serve Chemical Name:chroman-3-ylamine hydrochloride CAS:18518-71-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

chroman-3-ylamine hydrochloride

Chemical Name:chroman-3-ylamine hydrochloride
CAS.NO:18518-71-3
Synonyms:3-Chromanamine hydrochloride (1:1);3-Chromanamine,hydrochloride;2H-1-Benzopyran-3-amine, 3,4-dihydro-, hydrochloride (1:1);3-Chromanamine, hydrochloride
Molecular Formula:C9H12ClNO
Molecular Weight:185.651
HS Code:2932999099

Physical and Chemical Properties:
Melting point:N/A
Boiling point:256.8ºC at 760mmHg
Density:N/A
Index of Refraction:
PSA:35.25000
Exact Mass:185.060745
LogP:2.45110

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-Chromanamine hydrochloride (1:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Chromanamine, hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Chromanamine, hydrochloride Use and application,3-Chromanamine,hydrochloride technical grade,usp/ep/jp grade.


Related News: SAN FRANCISCO–(BUSINESS WIRE)–BetterUp, the inventor of virtual coaching and the first to democratize professional coaching across the entire enterprise, announced today that it is putting down roots in Europe with two new offices in Munich and London. 2-((4-chloro-6-((4-methoxyphenyl)amino)-1,3,5-triazin-2-yl)amino)ethan-1-ol manufacturers The pivotal TULIP (Treatment of Uncontrolled Lupus via the Interferon Pathway) phase III programme includes two trials, TULIP-1 and TULIP-2, that evaluated the efficacy and safety of anifrolumab versus placebo. 4-nitro-3-phenyl-isoxazol-5-ylamine suppliers “The Agency also noted that no effect was seen in the two studies that included patients from EU populations, including the most recent study which involved patients who were receiving the maximum and optimal treatment for their Parkinson’s disease,” EMA said. N-Cyclohexylmethylsulfon-methylurethan vendor & factory.